PMGC Holdings, Inc. (ELAB)
3.70
+0.14
(+3.93%)
USD |
NASDAQ |
Jan 15, 10:37
PMGC Holdings EPS Diluted (Quarterly): -19.64 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aclarion, Inc. | -2.930 |
| Acrivon Therapeutics, Inc. | -0.4729 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.616M |
| Revenue (Quarterly) | 0.2859M |
| Total Expenses (Quarterly) | 2.902M |
| Enterprise Value | -2.302M |
| Gross Profit Margin (Quarterly) | 14.94% |
| Profit Margin (Quarterly) | -915.0% |
| Earnings Yield | -36.67K% |
| Normalized Earnings Yield | -37794.68 |